Breathing & Blood Pressure
Launched by FLORIDA STATE UNIVERSITY · Nov 18, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Breathing & Blood Pressure" clinical trial is researching how obesity affects the heart and blood pressure responses during different breathing exercises. The goal is to better understand these effects in people who are healthy but overweight or obese. If you are between the ages of 18 and 65 and have a body mass index (BMI) of 40 or less, you might be eligible to participate. However, there are some important health conditions that would exclude you from joining, such as uncontrolled high blood pressure or certain heart and lung issues.
If you choose to participate, you can expect to take part in various breathing activities to help researchers measure how your heart and blood pressure respond. The study is currently looking for volunteers, and it's a chance to contribute to important research that could improve understanding of cardiovascular health in individuals with obesity. Keep in mind that this trial is not for individuals with significant health problems, recent surgeries, or those under 18 years old.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Body mass index values of ≤40 kg/m\^2
- Exclusion Criteria:
- • Not weight stable (\<5% change in body mass over the past six months)
- • Overt cardiovascular, neurological, renal, liver, and/or metabolic illness (e.g., diabetes mellitus)
- • Current, or history of uncontrolled, Stage 2 hypertension (blood pressure \>140 / 90 mmHg; anti-hypertensive medications are permitted)
- • Diagnosed obstructive sleep apnea
- • Previous bariatric surgery
- • Diagnosis or signs (e.g., values below the lower limit of normal) of overt airway disease(s)
- • Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes, vaping)
- * Per the POWERbreathe® company:
- • Patients who have undergone recent abdominal surgery and those with abdominal hernia.
- • Asthma patients who have a very low symptom perception and suffer from frequent, severe exacerbations or with an abnormally low perception of dyspnoea.
- • If a patient is suffering from a ruptured eardrum or any other condition of the ear.
- • Patients with marked elevated left ventricular end-diastolic volume and pressure.
- • Patients with worsening heart failure signs and symptoms after a respiratory/inspiratory muscle training (IMT) session
- • If you are suffering from a cold, sinusitis, or respiratory tract infection, we advise that you do not use your POWERbreathe IMT device.
- • Individuals who are not yet adults (infants, children, teenagers)
- • Pregnant (self-reported and urine pregnancy test conducted), lactating (self-reported), or post-menopausal (self-reported) females
- • Prisoners
About Florida State University
Florida State University (FSU) is a prestigious public research institution located in Tallahassee, Florida, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, FSU leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the medical community. The university fosters a collaborative environment that brings together multidisciplinary teams to design, implement, and analyze clinical studies, ensuring adherence to the highest ethical and scientific standards. Through its clinical trials, FSU aims to address critical health challenges and translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tallahassee, Florida, United States
Patients applied
Trial Officials
Joseph Watso, PhD
Principal Investigator
Florida State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials